149
Views
13
CrossRef citations to date
0
Altmetric
Review

Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?

, , , &
Pages 327-342 | Published online: 10 Jun 2017

Figures & data

Table 1 Drug case studies

Table 2 Country-specific processes for ODs

Table 3 Comparative HTA decisions for orphan oncology drugs and non-orphan oncology drugs